[Antithrombotic therapy in patients with peripheral artery diseases]

A V Svetlikov1, S V Sapelkin2, L É Ishpulaeva3

  • 1Clinical Hospital No122 named after L.G. Sokolov under the Federal Biomedical Agency of the Russian Federation, Saint Petersburg, Russia; North-Western State Medical University named after I.I. Mechnikov under the RF Ministry of Public Health, Saint Petersburg, Russia.

Insights

Atherothrombosis complications, including peripheral artery disease (PAD), are leading causes of death. Current antithrombotic therapies like aspirin are standard for PAD, but optimizing treatment after revascularization remains challenging.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Thrombosis Research

Background:

  • Atherothrombosis is a primary driver of cardiovascular disease mortality globally.
  • Peripheral artery disease (PAD) significantly worsens patient prognosis and increases mortality risk.
  • Optimizing antithrombotic therapy is crucial for managing ischemic complications in cardiovascular patients.

Purpose of the Study:

  • To review current antithrombotic therapy strategies for peripheral artery disease (PAD).
  • To evaluate the effectiveness of acetylsalicylic acid as a standard treatment for PAD.
  • To address the complexities of selecting antithrombotic therapy post-revascularization in PAD patients.

Main Methods:

  • Literature review of antithrombotic therapies for PAD over the past two decades.
  • Analysis of treatment guidelines and clinical trial data for acetylsalicylic acid.
  • Examination of challenges and emerging strategies for antithrombotic therapy post-revascularization.

Main Results:

  • Acetylsalicylic acid remains the established standard antithrombotic therapy for PAD.
  • Despite its use, ischemic complications persist as a significant concern in PAD patients.
  • Selecting optimal antithrombotic regimens after revascularization presents ongoing clinical challenges.

Conclusions:

  • Current antithrombotic strategies, while including aspirin, necessitate further refinement for PAD.
  • Improved antithrombotic approaches are needed to reduce ischemic events, particularly after revascularization.
  • Further research is essential to personalize and enhance antithrombotic therapy in cardiovascular disease management.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
384
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
343
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
415
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
438
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K